Zim Laboratories (NSE:ZIMLAB) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ZIMLAB Zim Laboratories Ltd NSE:ZIMLAB
82 GF Score
Price ₹115.89
GF Value ₹102.74
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Zim Laboratories Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

NSE:ZIMLAB
82GF Score
Zim Laboratories Ltd NSE:ZIMLAB
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zim Laboratories (NSE:ZIMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Zim Laboratories stock appears to be overvalued. The current stock price of ₹115.89 is trading 12.8% above its estimated GF Value™ of ₹102.74. GuruFocus considers Zim Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:ZIMLAB:

  • Interest Received:
  • GF Value™: ₹102.74 vs. price of ₹115.89 (12.8% above fair value)
  • GF Score™: 82/100 with 9 warning signs

No single metric tells the full story. See the NSE:ZIMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zim Laboratories Business Description

Other Exchanges 541400:India
Address Nelson Square, Chhindwara Road, Sadoday Gyan, Ground Floor, Opposite NADT, Nagpur, MH, IND, 440 013
Zim Laboratories Ltd is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. It is engaged in manufacturing &wholesale of pharmaceutical products, market research and research & development activities. The Group is mainly engaged in the business of pharmaceuticals. It has presence in India and Outside India. The company generates majority of revenue from India. Its products are Oral Thin Films, Pre-formulations Intermediates, Finished Formulations.
82GF Score

Get the complete analysis for NSE:ZIMLAB

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹115.89
Price
₹102.74
GF Value